Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Boehringer Ingelheim · 2005
ClinicalTrials.gov · Datasets · License: Public Domain · 2005
Open Source ↗
chronic-obstructivepulmonary-disease
pulmonary disease, chronic obstructive, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 912657
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.